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Background: Loop-mediated isothermal amplification (LAMP) is a novel strategy which amplifies DNA with high
sensitivity and rapidity under isothermal conditions. In the present study, the performance of the repetitive insertion
mobile element (RIME)-LAMP and human serum resistance-associated gene (SRA)-LAMP assays were evaluated
using clinical specimens obtained from four male patients from Luangwa and Zambezi valleys in Zambia and
Zimbabwe, respectively.
Findings: The cases reported in this preliminary communication were all first diagnosed by microscopy, through
passive surveillance, and confirmed by both RIME-LAMP and SRA-LAMP. A good correlation between microscopy
and LAMP was observed and contributed to staging and successful treatment of patient. RIME-LAMP and
SRA-LAMP complimented each other well in all the cases.
Conclusions: Both RIME-LAMP and SRA-LAMP were able to detect Trypanosoma brucei rhodesiense DNA in patient
blood and CSF and hence confirmed HAT in the parasitaemic patients. Our study indicates that the LAMP
technique is a potential tool for HAT diagnosis, staging and may be useful for making therapeutic decisions.
However, no statistically significant conclusion may be drawn due to the limited sample size used in the present
study. It is thus imperative to conduct a detailed study to further evaluate the potential of LAMP as a bedside
diagnostic test for HAT.
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Human African trypanosomiasis (HAT) or sleeping sick-
ness is one of the neglected tropical diseases (NTDs)
that mainly affect resource-poor countries in sub–
Saharan Africa [1]. HAT is caused by Trypanosoma
brucei rhodesiense (East and Southern Africa) and
Trypanosoma brucei gambiense (West and Central
Africa). It is transmitted through the bite of an infected* Correspondence: b.namangala@unza.zm
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distribution, and reproduction in any mediumtsetse fly (Glossina species) during a blood meal, with
several domestic and wild animals acting as reservoirs of
infection in rhodesiense HAT [1-3]. The disease com-
prises an early stage, characterized by the presence of
parasites in blood and lymph and a late stage, character-
ized by parasite invasion of the central nervous system
(CNS). In HAT endemic regions, routine disease diagno-
sis depends on clinical history of the patient, symptoms
and mainly visualization of parasites in body fluids by
microscopy [1,4]. However, HAT clinical symptoms are
not pathognomonic and may be confused with those of
other endemic febrile diseases. Although microscopy istral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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aemia in gambiense HAT patients, parasitological con-
firmation is relatively easier in rhodesiense HAT patients
because bloodstream trypanosomes are numerous [4].
Molecular techniques such as PCR have higher sensitiv-
ity and specificity for trypanosome detection [5,6]. How-
ever, the cost implications and requirement for highly
skilled manpower are obstacles to their wide application in
clinical settings in sub-Saharan Africa. Consequently, diag-
nosis of HAT in endemic regions remains unsatisfactory.
Loop-mediated isothermal amplification (LAMP) is a
novel strategy which amplifies DNA with high sensitivity
and rapidity under isothermal conditions (60-65°C), pro-
ducing large quantities of DNA within 30-60 minutes
[7]. This allows visual detection of amplicons by naked
eyes or through measurement of turbidity or fluores-
cence [8-10]. LAMP has been successfully developed
and applied in the detection of various pathogens in-
cluding protozoan parasites such as trypanosomes and
Babesia species [11-13]. Advances in the development of
trypanosome-specific LAMP have been made through
the identification of conserved sequences (used to design
highly specific LAMP tests) such as (i) the repetitive in-
sertion mobile element (RIME) within the sub-genus
Trypanozoon [6] and in particular (ii) the human serum
resistance-associated (SRA) gene, which defines T. b.
rhodesiense and therefore provides unequivocal identifi-
cation of the parasite [5,14,15]. The RIME-LAMP and
SRA-LAMP primers were previously designed by Njiru
et al. [6,15].
In the present study, we evaluated the performance of
RIME-LAMP and SRA-LAMP against routine micros-
copy, using clinical specimens obtained from four male
HAT patients from the Luangwa and Zambezi river val-
leys in Zambia and Zimbabwe, respectively. The patient
data is summarized in Table 1. Each of the HAT patients
complained of a headache, dizziness, general malaise,
intermittent fever, loss of appetite and fatigue. Clinical
examination revealed pale mucous membranes, jaundice
in some cases, enlarged lymph nodes, average body
temperature of about 39.5°C. In addition, patients A - C
exhibited impaired kidney function as evidenced by
greatly increased creatinine levels (data not shown) while
the HAT condition of patient D was less severe. All the
patients sought medical attention at the UniversityTable 1 Summary of patient data for some hospital reported
the period 2010 – 2012
Patient ID Gender Age Occupation C
A Male Adult Driver C
B Male Adult Telecommunication Company Employee C
C Male Adult Game Ranger M
D Male Adult Game Ranger MTeaching Hospital (UTH) in Lusaka, Zambia, where they
were admitted for one to two months.
After clinical examination, patient blood and CSF sam-
ples were collected. The presence of trypanosomes was
detected by microscopic examination of the buffy coat
following centrifugation of blood and white blood cell
(WBC) count in the case of CSF. The samples were then
sent to the School of Veterinary Medicine, University of
Zambia, for identification of trypanosome species by
LAMP. About 200 μl of each sample (blood or CSF) was
placed on a labeled FTAW Elute card (Whatman FTAW
Elute Cards, Whatman, UK) for DNA extraction accord-
ing to the manufacturer’s suggested protocol. The result-
ant DNA was stored at minus 30°C until use. A LAMP
reaction of 25 μl was performed using a Loopamp DNA
Amplification Kit (Eiken Chemical, Tochigi, Japan)
and the extracted DNA as template, as described by
Thekisoe et al. [11]. We used primers recently described
by Njiru et al. [6,15] for the RIME-LAMP and SRA-
LAMP, respectively. The reaction mixture was incubated
at 64°C for 30 minutes in a heat block (Dry Thermounit
DTU 1B, TAIEC Co., Saitama, Japan) and then at 95°C
for 2 minutes to terminate the reaction. The LAMP pro-
ducts were visualized using a transilluminator (WD,
H19, Good design award Co., Japan).
The presence of trypanosomes in the HAT patients
was confirmed by RIME-LAMP specific for the Trypano-
zoon subgenus group to which T. brucei complex
belongs (Figure 1A-B). SRA-LAMP further identified the
subspecies of the trypanosomes as the human-infective
T. b. rhodesiense (Figure 1A-B). The presence of T. b.
rhodesiense only in patient blood but not in CSF,
coupled with ≤ 5 WBCs/mm3 in CSF, signified early
stage HAT (Figure 1A, Table 2), which was treated with
suramin [1] along with supportive therapy. On the other
hand, the presence of the parasites in both blood and
CSF, coupled with >5 WBCs/mm3 in CSF, indicated late
stage HAT (Figure 1B, Table 2), which was treated with
melarsoprol [1] along with supportive therapy. All the
four treated HAT patients under study eventually recov-
ered from the disease.
Control of HAT heavily relies on accurate diagnosis
and effective case management [1,16]. In the present
study, we evaluated the performance of LAMP against
microscopy, using clinical specimens obtained from fourHAT cases from the Luangwa and Zambezi valleys during
ontracted HAT from Month/Year Reported
hama, near Mbambanda Sanctuary, Zambia December 2010
hama, near Mbambanda Sanctuary, Zambia January 2011
ashonaland, Hurungwe Safari Area, Zimbabwe January 2012
ashonaland, Hurungwe Safari Area, Zimbabwe May 2012
A B
Figure 1 Visual appearance of representative results for repetitive insertion mobile element (RIME)-LAMP and human serum
resistance-associated gene (SRA)-LAMP before and after treatment of a patient with Early (A) and Late (B) Stage human African
trypanosomiasis (HAT). Loopamp Fluorescent detection reagent was added to the reaction mixture at the beginning of the assay. The reactions
were incubated at 64°C for 30 minutes. In contrast to the light green background fluorescence in the negative samples, positive samples exhibit
a bright fluorescent green colour when visualized under the transilluminator. NC: Negative control (distilled water); PC: Positive control
(Trypanosoma brucei rhodesiense); BS: patient blood sample; CSF: patient cerebral spinal fluid sample.
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not only sensitive, but also very specific [6,15] and con-
firmed the microscopic observation of the trypanosomes
in patient blood and CSF. Four other HAT suspected
cases from Chama that tested negative by microscopy
also tested negative by LAMP (data not shown), demon-
strating good concordance between the two methods. In
agreement with Matovu et al. [17], RIME-LAMP and
SRA-LAMP exhibited similar sensitivities to detect T. b.
rhodesiense in the blood and CSF of HAT patients and
complimented each other.
According to our preliminary results, LAMP con-
firmed the standard staging criteria (microscopy and
WBC in CSF) [1,18,19], which led to successful treat-
ment of all the patients. Accurate staging of HAT is crit-
ical for the therapeutic decisions as demonstrated in the
present study. LAMP appears to be a potential tool for
HAT staging and may thus prove to be a useful guide in
making therapeutic decisions for HAT patients. How-
ever, in view of the fact that the presence of trypano-
somes alone without any CSF alterations may be
insufficient for second stage HAT diagnosis, HATTable 2 Summary of clinical data for the HAT patients admitt
period 2010 – 2012




D Yes Nostaging in this study also considered WBC count in the
CSF. It is noteworthy, that detection of trypanosome
DNA in CSF does not always signify active infection be-
cause of the potential for false positive cases resulting
from dead parasites in the blood entering the CNS
through the blood-brain-barrier or parasites that die in
the CSF, in particular following drug therapy [18,19].
The four rhodesiense HAT cases reported in the
present study were all detected through passive surveil-
lance. It is possible that these cases could represent sev-
eral others that may be unreported considering that
HAT affects the poorest among the poor remote rural
communities where social amenities are either weak or
non-existent. According to Odiit et al. [20], about 39%
of rhodesiense HAT cases and 92% of the deaths it
causes are unreported. Indeed, there are several unpub-
lished sporadic HAT cases reported at local health cen-
ters, mainly in the tsetse infested Luangwa and Zambezi
valleys linked to National Parks [21]. Of note, in 2008
alone, between the months of March and July, about 12
cases were reported in Chama district along the borders
of Zambia and Malawi. These cases were found amongsted to the University Teaching Hospital, Lusaka during the
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newly opened Mbambanda Zaro sanctuary [22]. Thus, in
agreement with Mwanakasale and Songolo [23], there is
need to increase both active and passive surveillance of
HAT as well as community sensitization, particularly in
HAT old foci where the disease appears to be re-
emerging.
We envisage that this study will stimulate research to
investigate the routine use of sensitive, specific and user-
friendly techniques such as LAMP in the detection of
emerging and re-emerging infectious diseases in en-
demic regions. Detailed studies using a larger sample
size for further evaluation of the LAMP technique for
diagnosis and staging of HAT patients, in particular in
studies on HAT treatment responses, are justifiable.
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